GTH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment...

Stats
Today's Volume	412 603
Average Volume	51 864.00
Market Cap	127.29M
EPS	$0 ( 2024-01-18 )
Next earnings date	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.110
ATR14	$0.00400 (0.10%)

Genetron Holdings Limited Correlation

10 Most Positive Correlations
CLGN	0.946
RING	0.916
IGLD	0.899
ORIC	0.87
USAU	0.865
SSRM	0.864
BTAI	0.858
DOOO	0.857
ISHG	0.857
SLQD	0.854

10 Most Negative Correlations
HQY	-0.854
RCMT	-0.843
CRSA	-0.832
LNSR	-0.82

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Genetron Holdings Limited Financials

Annual	2022
Revenue:	$650.71M
Gross Profit:	$281.43M (43.25 %)
EPS:	$-9.53

Q4	2022
Revenue:	$201.32M
Gross Profit:	$81.93M (40.70 %)
EPS:	$-6.44

Q3	2022
Revenue:	$201.32M
Gross Profit:	$81.93M (40.70 %)
EPS:	$-6.44

Q2	2022
Revenue:	$137.75M
Gross Profit:	$56.09M (40.72 %)
EPS:	$-2.53

Financial Reports:

No articles found.

Genetron Holdings Limited

Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.